Tobacco in the United States

Automotive Litigator Joins Premier Trial Firm Shook

Retrieved on: 
Tuesday, August 3, 2021

SAN FRANCISCO, Aug. 3, 2021 /PRNewswire/ --Litigator Amy Maclear moves to Shook, Hardy & Bacon to help build the firm's renowned team serving the cutting-edge automotive industry and other industries.

Key Points: 
  • SAN FRANCISCO, Aug. 3, 2021 /PRNewswire/ --Litigator Amy Maclear moves to Shook, Hardy & Bacon to help build the firm's renowned team serving the cutting-edge automotive industry and other industries.
  • "For many years I have admired the strategy component Shook lawyers bring to the courtroom," said Maclear, who has tried cases with the firm.
  • Shook's automotive team represents most of the world's leading auto manufacturers handling just about every type of automotive claim.
  • "Adding Amy strengthens our deep trial bench in the automotive space we are building at Shook," said Partner Amir Nassihi, who co-chairs Shook's Automotive Industry Group with Partner Janet Hickson.

Premier Trial Firm Shook Announces New Office Managing Partners

Retrieved on: 
Tuesday, July 20, 2021

Chicago Partner Amy Cho, business litigator, will take the reins from longtime, successful office managing partner Lynn Murray.

Key Points: 
  • Chicago Partner Amy Cho, business litigator, will take the reins from longtime, successful office managing partner Lynn Murray.
  • The new office managing partners are as follows:
    New York City Scott Chesin; and
    Learn more about the new office managing partners:
    Amy Chohandles complex commercial matters through trial and arbitration for insurance and reinsurance, banking and financial services, and technology and telecommunications industries.
  • He joined Shook in June when the firm added a St. Louis office.
  • To schedule an interview with Shook Chair Madeleine McDonough or firm office leadership, contact Media Relations Manager Heather McMichael, 816.559.2016, [email protected]
    Founded in 1889, Shook, Hardy & Bacon L.L.P.

KBRA Assigns Ratings to Northern Tobacco Securitization Corporation Tobacco Settlement Asset-Backed Bonds, Series 2006

Retrieved on: 
Monday, June 7, 2021

Kroll Bond Rating Agency (KBRA) assigns ratings to five classes of Tobacco Settlement Asset-Backed Bonds, Series 2006 issued by Northern Tobacco Securitization Corporation.

Key Points: 
  • Kroll Bond Rating Agency (KBRA) assigns ratings to five classes of Tobacco Settlement Asset-Backed Bonds, Series 2006 issued by Northern Tobacco Securitization Corporation.
  • The bonds are collateralized by an 80% portion of the tobacco settlement payments that are required to be made by tobacco manufacturers to the State of Alaska under the 1998 Tobacco Master Settlement Agreement (MSA).
  • Numerous smaller tobacco manufacturers joined the MSA after the OPMs and are referred to as subsequent participating manufacturers (SPMs).
  • After the MSA was signed, many states and local governments securitized some or all of their rights to receive future settlement payments.

Shook Partners Re-Elect Madeleine McDonough as Chair

Retrieved on: 
Thursday, April 29, 2021

b'KANSAS CITY, Mo., April 29, 2021 /PRNewswire/ -- Premier trial firm Shook, Hardy & Bacon has re-elected Madeleine McDonough for a second, five-year term as chair effective January 1, 2022.

Key Points: 
  • b'KANSAS CITY, Mo., April 29, 2021 /PRNewswire/ -- Premier trial firm Shook, Hardy & Bacon has re-elected Madeleine McDonough for a second, five-year term as chair effective January 1, 2022.
  • She began her first term as chair January 1, 2017, after 26 years with the firm.\n"I thank my colleagues for the continued opportunity to lead our firm," said Shook Chair Madeleine McDonough.
  • I wish Madeleine all the best in her second term as chair and offer her my heartfelt congratulations and full support.
  • "\nMcDonough brings more than three decades of experience at Shook to her role as chair.

Beard Management Inc. Advances from Application Acceptance to Filing Phase in the Premarket Tobacco Product Application Process

Retrieved on: 
Tuesday, April 27, 2021

b'AUSTIN, Texas, April 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Beard Management Inc., a leading global nicotine-based e-liquid company, announces today that its U.S. Food and Drug Administration (FDA) Premarket Tobacco Application (PMTA) has advanced to the Filing Phase, the second phase of the complex application process.

Key Points: 
  • b'AUSTIN, Texas, April 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Beard Management Inc., a leading global nicotine-based e-liquid company, announces today that its U.S. Food and Drug Administration (FDA) Premarket Tobacco Application (PMTA) has advanced to the Filing Phase, the second phase of the complex application process.
  • Founded in 2014, Beard remains committed to continuous product development while providing high-quality products to adult consumers.
  • Beard currently services retailers and distributors of every size nationally and in over 30 countries worldwide.
  • BRS prides itself on speed and flexibility while never compromising quality or its customers\xe2\x80\x99 confidential information.

Former FDA Legal Counsel Moves to Shook, Hardy & Bacon

Retrieved on: 
Tuesday, March 2, 2021

KANSAS CITY, Mo., March 2, 2021 /PRNewswire/ -- Former Food & Drug Administration Associate Chief Counsel Kristin Kaplan joins Shook, Hardy & Bacon, further expanding the firm's regulatory capabilities.

Key Points: 
  • KANSAS CITY, Mo., March 2, 2021 /PRNewswire/ -- Former Food & Drug Administration Associate Chief Counsel Kristin Kaplan joins Shook, Hardy & Bacon, further expanding the firm's regulatory capabilities.
  • "It is critical for our clients facing litigation to align with our regulatory team to anticipate and address developing legal developments."
  • Kaplan counseled FDA Commissioner on a variety of issues including new animal drug applications stemming from biotechnology and recalls of foods, animal foods and drugs.
  • "I am well-positioned to impart the lessons learned on what resonates with the FDA and what does not."

Shook Expands Trial Acumen in New York with Business Litigator

Retrieved on: 
Thursday, February 18, 2021

NEW YORK, Feb. 18, 2021 /PRNewswire/ --One month after announcing a New York office, Shook, Hardy & Bacon welcomes Partner William Vita, a seasoned litigator, to further expand the firm's Northeast presence.

Key Points: 
  • NEW YORK, Feb. 18, 2021 /PRNewswire/ --One month after announcing a New York office, Shook, Hardy & Bacon welcomes Partner William Vita, a seasoned litigator, to further expand the firm's Northeast presence.
  • He'll focus on complex business litigation in a variety of areas including defense of product liability claims for Shook's health, science and technology clients.
  • "I could not pass up the opportunity to practice law with this premier trial firm," said Vita from Long Island.
  • In January, Shook announced the addition of a New York office to complement its presence in Boston, Philadelphia and Washington, D.C.

Automotive Defense Litigators to Co-Lead Nationally Ranked Shook Class Action Team

Retrieved on: 
Thursday, February 4, 2021

LOS ANGELES and SAN FRANCISCO, Feb. 4, 2021 /PRNewswire/ --A pair of complex class action defense litigators will co-lead Shook, Hardy & Bacon's Class Action and Appellate Practice.

Key Points: 
  • LOS ANGELES and SAN FRANCISCO, Feb. 4, 2021 /PRNewswire/ --A pair of complex class action defense litigators will co-lead Shook, Hardy & Bacon's Class Action and Appellate Practice.
  • While this is an exciting time for product innovation, these new opportunities for our clients are also rife with class action litigation risk.
  • Led by Duncan, and previously Holly P. Smith, the team handled 680+ class action cases in the last decade, and been instrumental in favorably developing the law.
  • "Shook's Class Action team, which includes attorneys generating laudable results nationally, had our biggest year ever in 2020," said Duncan, recognized for her acumen in energy class action law and client service.

Philip Morris International Inc. to Host Webcast of 2021 Virtual Investor Day

Retrieved on: 
Monday, February 1, 2021

Philip Morris International Inc. (NYSE: PM) will host a live video webcast of presentations and Q&A session by senior management at its 2021 Investor Day at www.pmi.com/2021InvestorDay on Wednesday, February 10, 2021.

Key Points: 
  • Philip Morris International Inc. (NYSE: PM) will host a live video webcast of presentations and Q&A session by senior management at its 2021 Investor Day at www.pmi.com/2021InvestorDay on Wednesday, February 10, 2021.
  • The webcast will be held in a virtual format and provide live video of the entire session beginning on Wednesday, February 10, 2021, at approximately 8:30 a.m.
  • An archive of the webcast will be available at www.pmi.com/2021InvestorDay until 5:00 p.m.
  • Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company and its shareholders.

7 Daze Receives FDA Premarket Tobacco Product Application (PMTA) Acceptance Letter

Retrieved on: 
Tuesday, January 26, 2021

ONTARIO, Calif., Jan. 26, 2021 /PRNewswire/ -- 7 Daze, a leading premium e-liquid manufacturer, revealed today the receipt of its Premarket Tobacco Product Application (PMTA) acceptance letter from the U.S. Food and Drug Administration (FDA).

Key Points: 
  • ONTARIO, Calif., Jan. 26, 2021 /PRNewswire/ -- 7 Daze, a leading premium e-liquid manufacturer, revealed today the receipt of its Premarket Tobacco Product Application (PMTA) acceptance letter from the U.S. Food and Drug Administration (FDA).
  • 7 Daze submitted its application to the FDA seeking the authorization for the marketing and sale of its Reds Apple e-liquid products.
  • The application now moves to substantive review where the FDA will determine if 7 Daze's products are appropriate for the protection of public health.
  • "7 Daze has been working with leading consultants, scientists, and laboratories to submit our application to the FDA.